Company intelligence / Profile preview
Pharm-Sintez
- Ownership
- Private
- Development stage
- Commercial
Overview
Pharm-Sintez is a leading Russian pharmaceutical company with a full-cycle manufacturing process. It produces both original products and generics across multiple therapeutic areas. The company is recognized for its innovation in controlled release drugs and targeted delivery of radiopharmaceuticals. Its products have been proven safe and effective over many years of clinical use in Russia.[1][2] Pharm-Sintez.Lab specializes further in nuclear medicine with several proprietary diagnostic/therapeutic platforms already registered on the market.[5]
- Therapeutic areas
- OncologyEndocrinologyOtherGastroenterologyWomen's Health
- Modalities
- Small moleculesPeptidesRadiopharmaceuticals[2][5]
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Pharm-Sintez.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharm-Sintez.